Walleye Capital’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-80,837
| Closed | -$178K | – | 1976 |
|
|
2024
Q4 | $178K | Buy |
+80,837
| New | +$178K | ﹤0.01% | 1550 |
|
|
2024
Q2 | – | Sell |
-227,630
| Closed | -$610K | – | 2741 |
|
|
2024
Q1 | $610K | Buy |
227,630
+13,630
| +6% | +$36.5K | ﹤0.01% | 1284 |
|
|
2023
Q4 | $640K | Buy |
+214,000
| New | +$640K | ﹤0.01% | 1077 |
|
|
2023
Q2 | – | Sell |
-12,296
| Closed | -$19.6K | – | 2315 |
|
|
2023
Q1 | $19.6K | Buy |
+12,296
| New | +$19.6K | ﹤0.01% | 1696 |
|
|
2022
Q4 | – | Sell |
-698,343
| Closed | -$4.68M | – | 2270 |
|
|
2022
Q3 | $4.68M | Sell |
698,343
-26,111
| -4% | -$175K | 0.09% | 233 |
|
|
2022
Q2 | $4.61M | Buy |
724,454
+417,773
| +136% | +$2.66M | 0.13% | 185 |
|
|
2022
Q1 | $1.42M | Buy |
306,681
+145,932
| +91% | +$677K | 0.04% | 459 |
|
|
2021
Q4 | $804K | Buy |
+160,749
| New | +$804K | 0.03% | 695 |
|
|
2020
Q1 | – | Sell |
-300
| Closed | -$18K | – | 653 |
|
|
2019
Q4 | $18K | Buy |
+300
| New | +$18K | ﹤0.01% | 573 |
|
|
2019
Q3 | – | Sell |
-529
| Closed | -$25K | – | 648 |
|
|
2019
Q2 | $25K | Buy |
+529
| New | +$25K | ﹤0.01% | 376 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 451 |
|